Alerts will be sent to your verified email
Verify Email
GANGAPHARM
|
Ganga Pharma.
|
Kobo Biotech
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.2 % | -1.77 % | -8.9 % |
|
5yr average Equity Multiplier
|
1.4 | 4.06 | 1.02 |
|
5yr Average Asset Turnover Ratio
|
0.33 | 0.54 | 0.0 |
|
5yr Avg Net Profit Margin
|
2.35 % | -3.79 % | 0.0 |
|
Price to Book
|
0.0 | 0.0 | 4.84 |
|
P/E
|
139.02 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
183.46 Days | 0.0 | 0.0 |
|
Inventory Days
|
158.14 Days | 89.28 Days | 0.0 |
|
Days Receivable
|
120.91 Days | 0.0 | 0.0 |
|
Days Payable
|
141.14 Days | 147.48 Days | 68.55 Days |
|
5yr Average Interest Coverage Ratio
|
1.42 | 0.99 | 0.0 |
|
5yr Avg ROCE
|
4.7 % | 11.79 % | -8.89 % |
|
5yr Avg Operating Profit Margin
|
3.58 % | 8.83 % | 0.0 |
|
5 yr average Debt to Equity
|
0.3 | 1.62 | 0.0 |
|
5yr CAGR Net Profit
|
-23.43 % | n/a | -28.89 % |
|
5yr Average Return on Assets
|
0.85 % | -0.89 % | -8.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.02 % | 44.95 % | 42.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-10.69 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ganga Pharma.
|
Kobo Biotech
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|